NewsRoom Articles - NetworkNewsWire

MondayApr 13, 2026 11:15 am

Safe Pro Group Inc. (NASDAQ: SPAI) Appoints Chief Operating Officer, Is Also Awarded Government Support Order for its Edge Processing Solution

Safe Pro Group, a developer of security and defense solutions, has appointed decorated SOCOM Joint Acquisition Task Force Commander Jarret Mathews as Chief Operating Officer. Mathews brings more than 25 years of experience to the table, with expertise in operational leadership, defense acquisition, and advanced technology integration. Safe Pro Group was also awarded a support contract for their AI Edge Processing solution contract awarded earlier by the U.S. Government. Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security, and situational awareness solutions, recently announced the appointment of Colonel (Ret.) Jarret Mathews as Chief Operating Officer (“COO”) (https://nnw.fm/FGCY0). Before…

MondayApr 13, 2026 10:30 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Nears Restart of Gold Production this Quarter with First Gold Pour on the Horizon

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)and may include paid advertising. Junior Canadian near-term gold producer LaFleur Minerals is positioned to restart operations at its Beacon Gold Mill in Canada’s prolific Abitibi Greenstone Belt LaFleur will use a bulk sample remaining from the previous company’s operations at its nearby Swanson Gold Project to produce its first gold pour, with the aim to increase the daily processing capacity of the mill over the next year Gold’s spot price has roughly doubled since January of last year and, although the price has fluctuated in response to geopolitical pressures…

MondayApr 13, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Offers World’s First Voice-Enabled AI-Powered Drug and Alcohol Platform for Workplace Substance Abuse Screening

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. Workplace substance misuse costs U.S. employers over $81 billion annually through lost productivity, accidents, healthcare costs, and liability, with studies indicating that up to 40% of industrial workplace fatalities involve alcohol misuse. MindBio is introducing the world’s first AI-powered voice analytics system to detect drug and alcohol impairment in real time, initially targeting the South American mining sector, where heavy machinery and remote operations make safety monitoring critical. Such advanced screening technology has relevance to a global market spanning a range of safety-sensitive industries, including…

MondayApr 13, 2026 9:00 am

Rail Vision Ltd. (NASDAQ: RVSN) Targets Growing Billion-Dollar Train Safety Market with AI Obstacle Detection Systems

The global train collision avoidance system market is expected to reach $13.32 billion by 2030, growing at a compound annual growth rate (“CAGR”) of an estimated 15%. Rail Vision’s offerings have been described as AI-powered perception systems that allow rail operators to predict and prevent collisions. The company's two flagship products serve different operational environments but share the same underlying technological architecture. The global train collision avoidance market is undergoing a dramatic transformation, driven by the convergence of advanced camera systems and artificial intelligence. Rail Vision Ltd. (NASDAQ: RVSN, FSE: C80) is positioning itself squarely at the center of that…

FridayApr 10, 2026 11:15 am

Frontieras North America Inc. Unlocks Value in America’s Energy Future

Frontieras is developing breakthrough technologies that convert abundant solid hydrocarbons such as coal into cleaner fuels, hydrogen and industrial energy products. Central to this strategy is the company’s patented FASForm(TM) Solid Carbon Fractionation process. The company has not only developed its technology but is moving toward commercialization. Frontieras North America is emerging as a noteworthy innovator and attractive potential investment opportunity by addressing one of the most critical challenges facing modern technology: the rapidly growing demand for reliable, affordable electricity. As artificial intelligence (“AI”) and data-intensive computing expand, global electricity demand is projected to soar, with some analysts estimating AI-related…

FridayApr 10, 2026 10:30 am

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Advances Ukraine Defense Initiatives as Electronic Warfare Reshapes Battlefield

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF)and may include paid advertising. The war in Ukraine has demonstrated how electronic warfare can directly influence battlefield outcomes. The ability to interpret spatial data, maintain situational awareness and operate effectively in degraded signal environments is becoming increasingly important. SPARC AI has appointed a ground referral partner connected to Ukraine, a move intended to strengthen its engagement within the region and support potential deployment of its spatial intelligence capabilities. Electronic warfare has become one of the defining elements of modern conflict in Ukraine, where signal disruption, drone countermeasures and navigation…

FridayApr 10, 2026 9:45 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Accelerates Cancer Care Innovation with Liora Technologies Acquisition and Leadership Expansion

LIXT is advancing its lead compound LB-100 across different clinical programs aimed at difficult-to-treat cancers The company’s acquisition of Liora Technologies introduces a complementary therapy platform with recurring revenue potential These updates underscore LIXTE’s broader strategy: integrating drug development and med-tech innovation to redefine cancer treatment LIXTE Biotechnology (NASDAQ: LIXT) is executing a differentiated strategy in oncology, extending beyond traditional drug development into a more integrated and multi-dimensional approach to cancer care. With the company’s lead clinical candidate, LB-100, advancing through trials and the addition of Liora Technologies to its platform, they are positioning themselves at the nexus of pharmaceutical…

FridayApr 10, 2026 9:00 am

Rail Vision Ltd. (NASDAQ: RVSN) Positions AI-Powered Collision Avoidance Tech as Solution to Rail Safety Mandates

The National Transportation Safety Board (“NTSB”) has intensified its focus on collision-prevention technologies following multiple rail incidents. Rail Vision’s proprietary sensor systems are designed to address key railway safety challenges by combining advanced imaging technologies with artificial intelligence and deep learning algorithms. The company’s technology is also designed to integrate with existing rail infrastructure, providing flexibility for operators seeking to upgrade safety capabilities without requiring extensive system overhauls. Rail-safety regulators are increasingly calling for advanced collision-avoidance systems as rail networks grow more complex, and Rail Vision’s (NASDAQ: RVSN, FSE: C80) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological…

FridayApr 10, 2026 9:00 am

Global Energy Pressures Elevate the Importance of New Supply Frontiers

NetworkNewsWire Editorial Coverage: Escalating geopolitical tensions and renewed disruptions to key shipping corridors, particularly around the Strait of Hormuz, are once again highlighting a persistent vulnerability: global energy security remains fragile. Despite years of diversification efforts, both the United States and Europe continue to face exposure to supply disruptions capable of cascading through economies, industries and households. In this environment, companies focused on unlocking new energy resources in politically stable regions are attracting increased attention. Greenland Energy Company (NASDAQ: GLND) (Profile) is one such operator, advancing exploration activities within Greenland’s Jameson Land Basin. With the potential for a substantial oil…

ThursdayApr 09, 2026 10:30 am

Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

LIXT is advancing its lead candidate LB-100, a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments The company recently strengthened its position through a strategic partnership with Liora Technologies and the expansion of clinical trials These developments highlight Lixte’s broader mission: To improve cancer outcomes through innovation, combination-based therapeutic strategies Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with…

Financial news and publishing for public and private companies

Contact us: 512.354.7000